Login

We are 40! Talks at DFI - Steven Tsai, President of DFI Inc | Steven Tsai, CEO, DFI Inc2397:TAI 00:10:00

Share On Facebook Share On Twitter

Currently, Steven Tsai is the President of DFI Inc.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Exploits Discovery's Strategic Gold Exploration in Newfoundland
00:10:00
Advancing Sustainability and Inclusion: A Vision for Energy Transition| Javier Dib , CEO, AES Andes SA.
00:10:00
Todd River Resources' Q1 Update: Drilling, Surveying, and Upcoming Catalysts
00:10:00
The Journey of Steve Diggle and Artradis Fund Management to Vulpes Investment Management | Steve Diggle, Co-founder , Artradis Fund Management
00:10:00
Timing High Growth Equities: Perspectives from Mark Baribeau of Jennison Associates in Discussion with Witan Investment Trust's James Hart
00:10:00
Unlocking Financial Planning Insights: Bridget Sullivan Mermel | Founder and Financial Planner at Sullivan Mermel, Inc.
00:10:00
Startup Success in Hard Times|Amit Kumar,Partner,Accel
00:00:00
NetScientific changes "really paying off" - Dr. Ilian Iliev CHIEF EXECUTIVE OFFICER, Netscientific
00:10:00
Expanding Horizons: The Case for Adding International Stocks to Your Portfolio
00:10:00
Clocktower Technology Ventures partners with phenomenal entrepreneurs|Adriana Saman,Director,Clocktower Technology Ventures
00:10:00
John Zillmer and Kim Scott Discuss the Spin-Off Benefits and Future of Vestis | John Zillmer, CEO, Aramark.
00:10:00
Marinemine: Focused on Lithium and Gold Exploration in Western Australia

© 2026 Nehu